Menin regulates colonic epithelial cell growth through LXR repression

NIH RePORTER · NIH · R03 · $121,500 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY Despite many advances in diagnosis and treatment, colorectal cancer (CRC) remains one of the leading causes of cancer-related morbidity and mortality worldwide. Understanding factors in the colonic epithelial that promote colonic adenoma formation and subsequent development of CRC are of critical importance. We have shown that menin, a nuclear scaffold protein that has both tumor suppressor and tumor promoter roles in a highly tissue specific manner, is over-expressed in CRC compared to benign colonic epithelium, and unbiased RNA-Seq revealed that menin inhibition leads to enhanced transcription of target genes of the liver X receptor (LXR), therefore demonstrating that menin represses LXR-mediated gene transcription. The LXRs, including LXRα and LXRβ, are nuclear receptors that are critical for maintaining cellular cholesterol homeostasis, and increased LXR-mediated gene transcription can lead to suppression of CRC growth. However, the mechanism whereby menin represses LXR-mediated gene transcription as well as the involvement of menin in progression through the colon adenoma-carcinoma sequence is currently unknown and serves as the focus of this application. Our data shows that LXR target genes are the most significantly upregulated after menin inhibition in CRC cells, and that menin binds to LXR response elements (LXREs) with LXRα and inhibits the recruitment of RNA polymerase II. Furthermore, the increase in LXR-mediated gene transcription induced by menin inhibition has functional consequences, leading to decreased levels of cellular cholesterol in CRC cells and enhancing sensitivity of CRC cells to lipid starvation. As the importance of the interaction between menin and the LXRs in the colonic epithelial is uncertain, our findings lead to a novel hypothesis that menin upregulation in the colonic epithelium inhibits LXR activity, enriches cellular cholesterol, and promotes progression along the adenoma-carcinoma sequence. We will test this hypothesis using innovative methods and novel strategies to define the mechanism whereby menin represses LXR-mediated gene transcription. Furthermore, we will determine whether menin, and its repression of LXR-mediated transcription, are important for promoting progression through the adenoma-carcinoma sequence in the colonic epithelium both in vitro and in vivo. These experiments will provide important insights into the role of menin in both the colonic epithelium and epithelial progression through the adenoma-carcinoma sequence. Moreover, these experiments will serve as a platform for the development of future proposals that will have application to CRC prevention and treatment. Additionally, it is expected that this R03 award will be critical to facilitating future publication generation, a R01 grant application, and the PI's transition to independence.

Key facts

NIH application ID
9936437
Project number
5R03DK120946-02
Recipient
UNIVERSITY OF PENNSYLVANIA
Principal Investigator
Bryson William Katona
Activity code
R03
Funding institute
NIH
Fiscal year
2020
Award amount
$121,500
Award type
5
Project period
2019-06-01 → 2021-11-30